pág. 159
Mining the genome for causes and cures of neurological disease.
Andrew P. Lieberman, Imke Puls, Kenneth H. Fischbeck
pág. 161
A compendium of specific motifs for diagnosing GPCR subtypes.
Teresa K. Attwood
pág. 162
pág. 166
pág. 166
Rebecca Craven, David Cutler
pág. 167
pág. 169
Cysteine mutants as chemical sensors for ligand-receptor interactions.
Bernard Foucaud, Philippe Perret, Thomas Grutter
pág. 170
Glutamate signalling in non-neuronal tissues.
Timothy M. Skerry, Paul G. Genever
pág. 174
Purine-mediated signalling in pain and visceral perception.
Geoffrey Burnstock
pág. 182
GABA[sub A] receptor subtypes: dissecting their pharmacological functions.: dissecting their pharmacological functions.
Uwe Rudolph, Florence Crestani, Hanns Mohler
pág. 188
Biological and clinical implications of the MTHFR C677T polymorphism.
Jorn Schneede, Per Magne Ueland, Steinar Hustad
pág. 195
FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition.: signalling pathways, biological responses and therapeutic inhibition.
Michael J. Cross, Lena Claesson-Welsh
pág. 201
A lot of gain but not much pain.
Anthony H. Dickenson
pág. 208
It's a SNP--a loose-leaf bible for bioentrepreneurs.
Robert Kerwin
pág. 209
© 2001-2024 Fundación Dialnet · Todos los derechos reservados